• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

CMS Grants AABB as an Accrediting Organization for Laboratories Performing HLA Testing

May 23, 2014

Facilities performing human leukocyte antigen (HLA) testing for clinical use must be accredited.  The Centers of Medicare and Medicaid Services (CMS) announced that HLA testing of blood donors for transfusion related acute lung injury (TRALI) risk reduction can be classified as either histocompatibility or general immunology.  This classification allows the AABB to be an accrediting organization.  If there are any questions concerning laboratory accreditation of HLA testing, they should be directed to the AABB accreditation department.

Reference

1. AABB Weekly Report. May 9, 2014.  Vol 20.  No 16.

Filed Under

  • News
  • Policy and Guidelines
  • Quality Control and Regulatory

Recommended

  • Randomized Noninferiority Trial of Restrictive Transfusion Thresholds for Patients with Acute Myocardial Infarction

  • Frequent Donors Give More Blood but Are More Likely to be Iron Deficient

  • Increased Blood Use and Cost for Emergency Transfusions with Whole Blood Compared to Packed Red Blood Cells

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Locally Transmitted Malaria in the United States

  • Global Platelet Transfusion Practices for Patients in the ICU

  • Plasma Equivalent to Clotting Factor Concentrates for Initial Resuscitation of Patients with Severe Trauma

  • Personalized Prediction Model of Prophylactic Platelet Transfusions for Preterm Infants

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley